5-methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole, 500mg

2-Butanol, min 98,5 %, pour la synthèse, 500 ml, emballage en verre

1-(2-(4-Methoxyphenyl)cyclopropyl)ethan-1-one, 90%, 5g

ethyl 5-bromo-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate, 98%, 500mg

Électrode ROTIPHORESE®, 1 pièce

Bleu de bromothymol, 5 g

BENZYL 4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE, 95.0%, 100g

N~1~-(3,4-difluorophenyl)glycinamide hydrochloride, 95.0%, 1g

1-(4-Methoxy-phenyl)-2,2-dimethyl-piperazine, 95.0%, 1g

tert-Butyl 7-(3-hydroxypropyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate, 95.0%, 100mg

5-BROMO-3-ISOPROPOXYPYRIDIN-2-AMINE, 95.0%, 250mg

(S)-3-(3-Fluorophenyl)-3-(2-phenylacetamido)propanoic acid, 97%, 250mg

tert-Butyl (3-methylazetidin-3-yl)carbamate hydrochloride, 95.0%, 10g